Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

53.01 +0.04 (+0.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,858,343
Open 53.10
Bid (Size) 50.89 (1)
Ask (Size) 53.88 (2)
Prev. Close 52.97
Today's Range 52.65 - 53.25
52wk Range 37.07 - 57.82
Shares Outstanding 1,250,690,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics. 
Via Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+8.18%
+8.18%
1 Month
-1.40%
-1.40%
3 Month
-1.36%
-1.36%
6 Month
-2.64%
-2.64%
1 Year
+42.42%
+42.42%

More News

Read More
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
Via Benzinga
Looking Into Sanofi's Recent Short Interest
Via Benzinga
(SNY) - Analyzing Sanofi's Short Interest
Via Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
Via Benzinga
Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
Via Benzinga
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
Via Benzinga
Topics Stocks
Exposures US Equities
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today?
Via Benzinga
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories
Via Benzinga
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray
Via Benzinga
Exposures Product Safety
3 Stocks to Buy to Ride Europe’s Coming Market Surge
Via InvestorPlace
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
Via Benzinga
Exposures COVID-19
This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now
Via The Motley Fool
'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi
Via Benzinga
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
Via InvestorPlace
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood'
Via Investor's Business Daily
Could This Medicine Be the Next Winner for Novartis?
Via The Motley Fool
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth
Via Benzinga
Exposures Product Safety
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Via The Motley Fool
2 Biotech Stocks That Could Make You Richer
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.